EUVIMEDEUVIMED entdecken
Multizentrische Studie

Mutation Rate of AmpC β-Lactamase–Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution

Alexis Maillard iD, Laurent Dortet, Tristan Delory, Matthieu Lafaurie, Alexandre Bleibtreu, Treatment of AmpC producing Enterobacterales study group

Clinical Infectious Diseases · 19.07.2024 · 79 (1) · 52-55

DOI: 10.1093/cid/ciae160 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 25.03.2024. Verfasst von Alexis Maillard und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and Sorbonne Université, Paris, France. Hauptthemen laut MEDLINE: beta-Lactamases, Bacterial Proteins, Anti-Bacterial Agents, Enterobacteriaceae. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 12 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In a retrospective multicenter study of 575 patients with bloodstream infections or pneumonia due to wild-type AmpC β-lactamase–producing Enterobacterales, species with low in vitro mutation rates for AmpC derepression were associated with fewer treatment failures due to AmpC overproduction (adjusted hazard ratio, 0.5 [95% CI, .2–.9]). However, compared to cefepime/carbapenems, using third-generation cephalosporins as definitive therapy remained associated with this adverse outcome (15% vs 1%).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

beta-LactamasesBacterial ProteinsAnti-Bacterial AgentsEnterobacteriaceaeEnterobacteriaceae InfectionsMutation RateHumansRetrospective StudiesMiddle AgedMaleFemaleMicrobial Sensitivity TestsBacteremiaAgedCephalosporins

Stichwörter der Autor:innen

AmpC β-lactamaseEnterobacteralesantibiomicrobial therapybloodstream infectionpneumonia

Substanzen

beta-LactamasesAmpC beta-lactamasesBacterial ProteinsAnti-Bacterial AgentsCephalosporins

Autor:innen und Institutionen

  • Department of Infectious Diseases, Pitié-Salpêtrière Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP) and Sorbonne Université, Paris, France.
  • Department of Bacteriology-Hygiene, Bicêtre Hospital, AP-HP, Le Kremlin-Bicêtre, France.
  • Faculty of Medicine, UMR-1184, Inserm, University Paris-Saclay, Le Kremlin-Bicêtre, France.
  • French National Reference Center for Antimicrobial Resistance, Le Kremlin-Bicêtre, France.
  • Clinical Research Unit, Annecy-Genevois Hospital, Epagny-Metz-Tessy, France.
  • Department of Infectious Diseases, Saint-Louis Hospital, AP-HP, Paris, France.

ORCID-Profile: Alexis Maillard

Zitieren

APA

Maillard, A., Dortet, L., Delory, T., Lafaurie, M., Bleibtreu, A., & Treatment of AmpC producing Enterobacterales study group (2024). Mutation Rate of AmpC β-Lactamase–Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution. Clinical Infectious Diseases, 79(1), 52-55. https://doi.org/10.1093/cid/ciae160

Vancouver

Maillard A, Dortet L, Delory T, Lafaurie M, Bleibtreu A, Treatment of AmpC producing Enterobacterales study group. Mutation Rate of AmpC β-Lactamase–Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution. Clinical Infectious Diseases. 2024;79(1):52-55. doi:10.1093/cid/ciae160

BibTeX
@article{Maillard2024,
  author = {Maillard, Alexis and Dortet, Laurent and Delory, Tristan and Lafaurie, Matthieu and Bleibtreu, Alexandre and Treatment of AmpC producing Enterobacterales study group, Treatment of AmpC producing Enterobacterales study group},
  title = {Mutation Rate of AmpC β-Lactamase–Producing Enterobacterales and Treatment in Clinical Practice: A Word of Caution},
  journal = {Clinical Infectious Diseases},
  year = {2024},
  volume = {79},
  number = {1},
  pages = {52--55},
  doi = {10.1093/cid/ciae160}
}
Kostenlos starten →